NEW YORK (GenomeWeb) – Paradigm Diagnostics announced today that it has secured an additional $3 million in funding as part of a planned $7 million Series B round of financing.
The investment was made by New Science Ventures and follows a $3.5 million investment led by Mesa Verde Venture Partners in November. New Science Ventures Partner Grace Colón also joined Paradigm's board.